China
· Delayed Price · Currency is CNY Jilin Aodong Pharmaceutical Group Statistics
Total Valuation
Jilin Aodong Pharmaceutical Group has a market cap or net worth of CNY 21.90 billion. The enterprise value is 21.37 billion.
| Market Cap | 21.90B |
| Enterprise Value | 21.37B |
Important Dates
The last earnings date was Monday, October 28, 2024.
| Earnings Date | Oct 28, 2024 |
| Ex-Dividend Date | Nov 8, 2024 |
Share Statistics
Jilin Aodong Pharmaceutical Group has 1.20 billion shares outstanding. The number of shares has decreased by -3.73% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.20B |
| Shares Change (YoY) | -3.73% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 7.75% |
| Float | 820.72M |
Valuation Ratios
The trailing PE ratio is 14.94 and the forward PE ratio is 9.11.
| PE Ratio | 14.94 |
| Forward PE | 9.11 |
| PS Ratio | 7.06 |
| PB Ratio | 0.76 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 151.06, with an EV/FCF ratio of -287.84.
| EV / Earnings | 14.95 |
| EV / Sales | 7.11 |
| EV / EBITDA | 151.06 |
| EV / EBIT | n/a |
| EV / FCF | -287.84 |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.24 |
| Quick Ratio | 1.77 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 15.40 |
| Debt / FCF | -29.34 |
| Interest Coverage | -0.86 |
Financial Efficiency
Return on equity (ROE) is 4.92% and return on invested capital (ROIC) is -0.20%.
| Return on Equity (ROE) | 4.92% |
| Return on Assets (ROA) | -0.19% |
| Return on Capital (ROIC) | -0.20% |
| Revenue Per Employee | 532,201 |
| Profits Per Employee | 253,227 |
| Employee Count | 5,646 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 1.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.99% in the last 52 weeks. The beta is 0.53, so Jilin Aodong Pharmaceutical Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +13.99% |
| 50-Day Moving Average | 15.81 |
| 200-Day Moving Average | 14.59 |
| Relative Strength Index (RSI) | 59.43 |
| Average Volume (20 Days) | 25,917,237 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Jilin Aodong Pharmaceutical Group had revenue of CNY 3.00 billion and earned 1.43 billion in profits. Earnings per share was 1.23.
| Revenue | 3.00B |
| Gross Profit | 1.24B |
| Operating Income | -96.95M |
| Pretax Income | 1.43B |
| Net Income | 1.43B |
| EBITDA | 112.89M |
| EBIT | -96.95M |
| Earnings Per Share (EPS) | 1.23 |
Balance Sheet
The company has 2.97 billion in cash and 2.18 billion in debt, giving a net cash position of 788.59 million or 0.66 per share.
| Cash & Cash Equivalents | 2.97B |
| Total Debt | 2.18B |
| Net Cash | 788.59M |
| Net Cash Per Share | 0.66 |
| Equity (Book Value) | 29.26B |
| Book Value Per Share | 24.25 |
| Working Capital | 2.93B |
Cash Flow
In the last 12 months, operating cash flow was 306.14 million and capital expenditures -380.39 million, giving a free cash flow of -74.24 million.
| Operating Cash Flow | 306.14M |
| Capital Expenditures | -380.39M |
| Free Cash Flow | -74.24M |
| FCF Per Share | -0.06 |
Margins
Gross margin is 41.31%, with operating and profit margins of -3.23% and 47.58%.
| Gross Margin | 41.31% |
| Operating Margin | -3.23% |
| Pretax Margin | 47.47% |
| Profit Margin | 47.58% |
| EBITDA Margin | 3.76% |
| EBIT Margin | -3.23% |
| FCF Margin | -2.47% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 2.12%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 2.12% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 57.34% |
| Buyback Yield | 3.73% |
| Shareholder Yield | 5.85% |
| Earnings Yield | 6.69% |
| FCF Yield | -0.34% |
Stock Splits
The last stock split was on June 19, 2017. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 19, 2017 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
Jilin Aodong Pharmaceutical Group has an Altman Z-Score of 3.95.
| Altman Z-Score | 3.95 |
| Piotroski F-Score | n/a |